Viewing Study NCT04370834


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2026-01-01 @ 12:12 AM
Study NCT ID: NCT04370834
Status: TERMINATED
Last Update Posted: 2025-02-04
First Post: 2020-04-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Tocilizumab for Patients With Cancer and COVID-19 Disease
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-05-28
Start Date Type: ACTUAL
Primary Completion Date: 2021-01-14
Primary Completion Date Type: ACTUAL
Completion Date: 2021-01-14
Completion Date Type: ACTUAL
First Submit Date: 2020-04-30
First Submit QC Date: None
Study First Post Date: 2020-05-01
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-05-28
Results First Submit QC Date: None
Results First Post Date: 2021-06-04
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-01-14
Last Update Post Date: 2025-02-04
Last Update Post Date Type: ACTUAL